Back to top
more

Procter & Gamble (PG)

(Real Time Quote from BATS)

$166.95 USD

166.95
1,362,519

-0.76 (-0.45%)

Updated Nov 11, 2024 11:48 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value B Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 37% (93 out of 250)

Industry: Soap and Cleaning Materials

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Procter & Gamble (PG) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

Procter & Gamble (PG) closed the most recent trading day at $148.08, moving -0.52% from the previous trading session.

Should You Invest in the Vanguard Consumer Staples ETF (VDC)?

by Zacks Equity Research

Sector ETF report for VDC

Is Fidelity High Dividend ETF (FDVV) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for FDVV

Why You Must Consider Colgate (CL) Stock Before Q2 Earnings

by Zacks Equity Research

Colgate (CL) is well-poised on its innovation efforts, pricing actions, digital capabilities and progress on revenue growth management initiatives.

Should You Invest in the Fidelity MSCI Consumer Staples Index ETF (FSTA)?

by Zacks Equity Research

Sector ETF report for FSTA

Constellation Brands (STZ) Q1 Earnings & Sales Top Estimates

by Zacks Equity Research

Constellation Brands' (STZ) Q1 results reflect strength in its beer business and cost-efficiency initiatives. As a result, it retains the fiscal 2024 view.

Procter & Gamble (PG) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

In the latest trading session, Procter & Gamble (PG) closed at $149.38, marking a -0.41% move from the previous day.

Investors Heavily Search Procter & Gamble Company (The) (PG): Here is What You Need to Know

by Zacks Equity Research

Recently, Zacks.com users have been paying close attention to P&G (PG). This makes it worthwhile to examine what the stock has in store.

Clorox (CLX) Surpasses the Industry in a Year: Here's How

by Zacks Equity Research

Clorox (CLX) is poised to benefit from pricing gains and cost savings efforts, along with a solid innovation pipeline, digital transformation and its IGNITE strategy.

Here's Why Molson Coors (TAP) is Marching Ahead of Its Industry

by Zacks Equity Research

Although rising inflation is concerning, brand strength, product innovation and a revitalization plan bode well for Molson Coors (TAP).

Nalak Das headshot

5 Blue-Chip Stocks to Buy Amid a Muted Dow in First-Half 2023

by Nalak Das

We have narrowed our search to five blue-chip (components of Dow) stocks with strong potential for 2023. These are: CAT, CRM, WMT, PG and MCD.

Can Growth Efforts Counter Boston Beer's (SAM) Supply-Chain Woes?

by Zacks Equity Research

Although drab seltzer unit, dismal shipments and depletions, and cost woes remain concerning, pricing actions, product innovation and cost-saving efforts are likely to aid Boston Beer (SAM).

Procter & Gamble (PG) Dips More Than Broader Markets: What You Should Know

by Zacks Equity Research

Procter & Gamble (PG) closed the most recent trading day at $148.46, moving -0.99% from the previous trading session.

Graphic Package Holding and Vornado Realty have been highlighted as Zacks Bull and Bear of the Day

by Zacks Equity Research

Graphic Package Holding and Vornado Realty have been highlighted as Zacks Bull and Bear of the Day.

Derek Lewis headshot

3 Low-Beta Stocks Suited Nicely for Risk-Averse Investors

by Derek Lewis

Low-beta stocks are less susceptible to the broader market's movements, helping to limit those spooky price swings. And interestingly enough, analysts have recently become bullish on these three.

Brown-Forman (BF.B) to Sell Finlandia Vodka to Coca-Cola HBC

by Zacks Equity Research

Brown-Forman (BF.B) enters a deal to sell the Finlandia vodka brand to Coca-Cola HBC, following the brand's bleak prospects post the exit of its Russia operations.

Here's Why Procter & Gamble (PG) is an Attractive Pick Now

by Zacks Equity Research

Procter & Gamble (PG) is a lucrative pick on its ongoing business momentum, strength across businesses, pricing actions and productivity plans.

Here's Why Brown-Forman (BF.B) is Marching Ahead of Its Industry

by Zacks Equity Research

Brown-Forman (BF.B) is poised for growth on solid brand demand, acquisitions, portfolio premiumization, product innovation and strategic relationships amid cost headwinds.

Zacks Investment Ideas feature highlights: Adobe, McDonalds, Pepsi and Procter and Gamble

by Zacks Equity Research

Adobe, McDonalds, Pepsi and Procter and Gamble are part of the Zacks Investment Ideas article.

Ethan Feller headshot

Time to Buy These 4 Stocks with Multi-Decade Earnings Growth?

by Ethan Feller

Steady can sometimes be boring, but in investing, boring is profitable

Colgate (CL) Looks Solid on Pricing Action & Expansion Strategy

by Zacks Equity Research

Pricing actions, revenue management initiatives, innovation, brand strength and digital growth position Colgate (CL) for growth amid higher costs and currency headwinds.

Procter & Gamble Company (The) (PG) is Attracting Investor Attention: Here is What You Should Know

by Zacks Equity Research

P&G (PG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

P&G (PG) Is Considered a Good Investment by Brokers: Is That True?

by Zacks Equity Research

The average brokerage recommendation (ABR) for P&G (PG) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

Procter & Gamble (PG) Stock Sinks As Market Gains: What You Should Know

by Zacks Equity Research

In the latest trading session, Procter & Gamble (PG) closed at $145.06, marking a -0.24% move from the previous day.

Sheraz Mian headshot

Top Stock Reports for Procter & Gamble, Bank of America & Abbott Laboratories

by Sheraz Mian

Today's Research Daily features new research reports on 16 major stocks, including The Procter & Gamble Company (PG), Bank of America Corporation (BAC) and Abbott Laboratories (ABT).